A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation

Silvia Rossi, Caterina Motta, Valeria Studer, Fabrizia Monteleone, Valentina De Chiara, Fabio Buttari, Francesca Barbieri, Giorgio Bernardi, Luca Battistini, Gary Cutter, Olaf Stüve, Marco Salvetti, Diego Centonze

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint Dive into the research topics of 'A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation'. Together they form a unique fingerprint.

Medicine & Life Sciences